AISAP, a medical technology company developing AI-powered point-of-care assisted diagnosis (POCAD) solutions to transform medical ultrasound, has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, artificial intelligence (AI)-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform. The cloud-based platform combines four computer-assisted diagnosis (CADx) modules of valvular pathologies […] The post AI-powered point-of-care ultrasound system gains US FDA approval appeared first on Cardiovascular News .